Prophylaxis with gentamicin locking of chronic tunnelled central venous catheters does not cause bacterial resistance

J Fernández-Gallego1, M Martín, E Gutiérrez

  • 1Nephrology Department, Carlos Haya Hospital, Málaga, Spain. juan.fernandezgallego.sspa@juntadeandalucia.es

Insights

Gentamicin catheter locking in hemodialysis patients prevents bacterial resistance and ototoxicity. This 7-year study found low infection rates and no adverse effects, suggesting a safe and effective prophylaxis method.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chronic haemodialysis patients with central venous catheters are at risk of bacterial infections.
  • Gentamicin catheter locking is a prophylaxis strategy to reduce these infections and associated mortality.

Purpose of the Study:

  • To evaluate the development of bacterial resistance to gentamicin in pathogens.
  • To assess the incidence of clinical ototoxicity in patients receiving gentamicin prophylaxis.

Main Methods:

  • A 7-year prospective observational study of 101 chronic haemodialysis patients.
  • Universal asepsis protocol with intraluminal gentamicin (5mg/branch) + heparin locking post-dialysis.
  • Monitoring of gentamicin trough blood levels and diagnosis of bacteraemia based on standard criteria.

Main Results:

  • No bacterial resistance to gentamicin was observed in pathogens typically sensitive to the antibiotic.
  • No cases of clinical ototoxicity were reported among the study participants.
  • Low rates of hospitalization (3%), bacteraemia (0.11/catheter/1000 days), infectious mortality (1%), and catheter withdrawal (2%) due to bacteraemia were recorded.

Conclusions:

  • Intraluminal gentamicin locking prophylaxis is safe and does not induce bacterial resistance or ototoxicity.
  • The low dose of gentamicin used in this protocol may contribute to the absence of resistance and ototoxicity.
  • This prophylaxis method appears effective in reducing catheter-related infections in chronic haemodialysis patients.
Abstract

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...